Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma

NCT02621970 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

534

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Cisplatin 1
DRUG: Cisplatin 2
DRUG: Docetaxel
DRUG: Xeloda
RADIATION: Intensity-modulated radiotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]